ANXA5 and Abnormal retinal morphology: The pharmacologic effects of recombinant human Annexin A5 that might be of relevance to RVO and other retinal diseases include its anti-adherent [11], anti-inflammatory [18,24], anti-thrombotic [20], and cell-protecting effects [15,109].